Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Fixed Capital/Sales(x) 0.450.450.440.470.44

What is the latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 0.45 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.45
Mar20230.45
Mar20220.44
Mar20170.47
Mar20160.44

How is Fixed Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.45
0.00
Mar2023 0.45
2.27
Mar2022 0.44
-6.38
Mar2017 0.47
6.82
Mar2016 0.44 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Fixed Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,592.4 Cr -3.8% -3.9% -18.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,594.0 Cr -3.3% -6.9% -9.7% Stock Analytics
DIVIS LABORATORIES ₹162,722.0 Cr 1.7% -6.8% 25.4% Stock Analytics
CIPLA ₹127,508.0 Cr -0.9% 0.5% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,111.0 Cr -1.9% -1.3% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,225.0 Cr -1.2% -2% -9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-3.8%

-3.9%

-18.1%

SENSEX

-2.2%

-1.7%

-1.2%


You may also like the below Video Courses